Broncus Holding Corporation

HK$0.54As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2216Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 5Y CAGR (47.57%)
Div yield —
ROE (12.01%)
Medical Devices
Beta (5Y) 1.14
PE TTM —
TSR TTM (78.91%)
Mkt cap HK$284.6M
ROIC (9.04%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.62
14.90%
223.37%
Buy 8|12|4|6|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.02
0.01
23.21%
23.90%
31.21%
18.60%
Revenue$M
20.82
21.88
21.36
22.01
7.98%
8.23%
0.50%
3.60%
Peers (US$36.31M)
Cap (US$)
PE
58.52M
4.683x
34.98M
13.76x
36.27M
—
Capital
TTM
5Y
10Y
Leveragex
0.569
0.126
0.072
EBIT/Intx
0.450
1.132
1.231
Own earn%
534.54
20.66
25.19
Sh yield%
19.39
14.61
16.38
Owners
Insiders/Inst%
7.37
89.44
Short interest%
0.80
SBC / revenue%
2.41
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
5–9
$1 testx
—
Incr. ROIC%
0